Literature DB >> 16107226

Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: emerging insights for vascular integrity.

Peter Densen1.   

Abstract

Entities:  

Year:  2005        PMID： 16107226     DOI： 10.1007/s11908-005-0002-4

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  9 in total

Review 1.  Thrombotic microangiopathies.

Authors:  Joel L Moake
Journal:  N Engl J Med       Date:  2002-08-22       Impact factor: 91.245

Review 2.  Bacteria and diseases of unknown cause: hemolytic-uremic syndrome.

Authors:  Martin J Blaser
Journal:  J Infect Dis       Date:  2004-02-01       Impact factor: 5.226

Review 3.  The role of the endothelium in hemolytic uremic syndrome.

Authors:  C Zoja; M Morigi; G Remuzzi
Journal:  J Nephrol       Date:  2001 Nov-Dec       Impact factor: 3.902

Review 4.  Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking.

Authors:  J Liu; M Hutzler; C Li; L Pechet
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

Review 5.  Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.

Authors:  Amit X Garg; Rita S Suri; Nick Barrowman; Faisal Rehman; Doug Matsell; M Patricia Rosas-Arellano; Marina Salvadori; R Brian Haynes; William F Clark
Journal:  JAMA       Date:  2003-09-10       Impact factor: 56.272

6.  Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome.

Authors:  Tamara Manuelian; Jens Hellwage; Seppo Meri; Jessica Caprioli; Marina Noris; Stefan Heinen; Mihaly Jozsi; Hartmut P H Neumann; Giuseppe Remuzzi; Peter F Zipfel
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 7.  Mutations in CD46, a complement regulatory protein, predispose to atypical HUS.

Authors:  Timothy H J Goodship; M Kathryn Liszewski; Elizabeth J Kemp; Anna Richards; John P Atkinson
Journal:  Trends Mol Med       Date:  2004-05       Impact factor: 11.951

Review 8.  The human complement factor H: functional roles, genetic variations and disease associations.

Authors:  Santiago Rodríguez de Córdoba; Jorge Esparza-Gordillo; Elena Goicoechea de Jorge; Margarita Lopez-Trascasa; Pilar Sánchez-Corral
Journal:  Mol Immunol       Date:  2004-06       Impact factor: 4.407

Review 9.  Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation.

Authors:  Douglas P Blackall; Marisa B Marques
Journal:  Am J Clin Pathol       Date:  2004-06       Impact factor: 2.493
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.